A share of Surface Oncology Inc. (NASDAQ:SURF) closed at $0.97 per share on Monday, down from $0.97 day before. While Surface Oncology Inc. has underperformed by -0.10%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SURF fell by -43.27%, with highs and lows ranging from $2.09 to $0.56, whereas the simple moving average jumped by 15.57% in the last 200 days.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
On May 18, 2021, BTIG Research started tracking Surface Oncology Inc. (NASDAQ: SURF) recommending Buy.
Analysis of Surface Oncology Inc. (SURF)
Surface Oncology Inc.’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -87.80% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.30, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and SURF is registering an average volume of 731.57K. On a monthly basis, the volatility of the stock is set at 5.95%, whereas on a weekly basis, it is put at 5.62%, with a gain of 1.26% over the past seven days. Furthermore, long-term investors anticipate a median target price of $2.38, showing growth from the present price of $0.97, which can serve as yet another indication of whether SURF is worth investing in or should be passed over.
How Do You Analyze Surface Oncology Inc. Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.70%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 53.50% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in SURF shares?
The recent increase in stakes in SURF appears to be a result of several institutional investors and hedge funds increasing their positions. The company now owns 3,183,242 shares of the stock, with a value of $2.77 million, following the purchase of 3,183,242 additional shares during the last quarter. EcoR1 Capital, LLC made another decreased to its shares in SURF during the first quarter, downing its stake by -21.45%.
At the end of the first quarter, Tang Capital Management LLC increased its SURF holdings by 202.57% and now holds 1.3 million SURF shares valued at $1.13 million with the added 0.87 million shares during the period. SURF shares are owned by institutional investors to the tune of 53.50% at present.
